STAT5a was first identified as a “mammary gland factor”37, but its role in breast cancer progression has not been fully elucidated, as its activation has been shown to play a role in mammary tumour initiation38, and to maintain differentiation and suppress the EMT39. The gene discussed is STAT5A; the disease is breast cancer.